Testosterone Cypionate Cost in Hawaii (2026): Cash Prices, Insurance, and Savings

What Does Testosterone Cypionate Actually Cost in Hawaii?

The average cash-pay price for generic testosterone cypionate at Hawaii retail pharmacies is approximately $60 per month in 2026. This figure reflects a 200 mg/mL vial, the most commonly prescribed concentration for testosterone replacement therapy (TRT). Manufacturer list prices for various generic versions hover around $100 per month, but pharmacy acquisition costs and local competition pull the street price lower.

Pricing varies by island and pharmacy. Pharmacies on Oahu, particularly in the Honolulu metro area, tend to price competitively because of higher patient volume and multiple chain pharmacy options. Neighbor island pharmacies on Maui, Kauai, and the Big Island may charge $10 to $25 more per fill due to smaller distribution networks and higher overhead 1. Brand-name Depo-Testosterone typically runs $150 to $250 per month, making generic the default choice for cost-conscious patients.

A 1 mL vial of 200 mg/mL testosterone cypionate provides roughly four weeks of therapy at a standard dose of 100 mg weekly, or two weeks at 200 mg weekly. Your actual monthly cost depends on prescribed dose. Patients on 200 mg weekly will pay double the per-vial price since they use one vial every two weeks. The Endocrine Society's 2018 clinical practice guideline recommends starting doses of 75 to 100 mg weekly for most hypogonadal men, with adjustments based on serum testosterone levels measured at trough 2.

Hawaii Medicaid Does Not Cover Testosterone Cypionate

Hawaii Medicaid (Med-QUEST) does not include testosterone cypionate on its preferred drug list for male hypogonadism as of 2026. This means Medicaid beneficiaries in Hawaii face the full cash-pay price unless they pursue alternative coverage pathways.

Patients on Med-QUEST who have a confirmed diagnosis of hypogonadism (ICD-10 E29.1) can request a prior authorization exception. Approvals are rare but not impossible, particularly when the prescribing physician documents two morning serum testosterone levels below 300 ng/dL along with clinical symptoms consistent with androgen deficiency 3. The American Urological Association defines testosterone deficiency as a total testosterone concentration below 300 ng/dL on at least two separate fasting morning samples 3.

Dr. Shalender Bhasin, lead author of the Testosterone Trials, has stated: "The diagnosis of hypogonadism requires both consistently low testosterone levels and unambiguous signs and symptoms" 1. This diagnostic standard matters for coverage appeals because insurers and state Medicaid programs reference it when evaluating prior authorization requests.

For Hawaii Medicaid patients who cannot obtain coverage, the $60 per month cash-pay option or a compounded 503A formulation at roughly $80 per month remain the primary alternatives.

Compounded Testosterone Cypionate in Hawaii: Legal and Available

Compounded testosterone cypionate is legal in Hawaii through licensed 503A compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and must comply with both Hawaii Revised Statutes Chapter 461 and federal guidelines under Section 503A of the Federal Food, Drug, and Cosmetic Act 4.

The typical cost for compounded testosterone cypionate from a Hawaii-licensed 503A pharmacy is approximately $80 per month. That price is higher than the average generic cash-pay price of $60, which may seem counterintuitive. The difference reflects several factors: compounded formulations often include different carrier oils (such as grapeseed oil instead of cottonseed oil) for patients with sensitivities, custom concentrations (e.g., 250 mg/mL), and sometimes combination formulations that include ingredients like anastrozole.

Not every patient needs compounded testosterone. The decision framework is straightforward: choose generic manufactured testosterone cypionate ($60 per month) unless you have a documented allergy to cottonseed oil, need a non-standard concentration, or your prescriber has a specific clinical rationale for a compounded formulation. Hawaii has multiple 503A pharmacies licensed to compound testosterone, and several mainland 503A pharmacies ship to Hawaii addresses with valid prescriptions.

One critical distinction: 503B outsourcing facilities operate differently from 503A pharmacies. A 503B facility can produce compounded drugs in bulk without individual prescriptions and ships directly to healthcare providers. Several telehealth TRT clinics that serve Hawaii patients source their testosterone from 503B facilities, which sometimes results in lower per-unit costs passed to the patient.

Insurance Coverage for Testosterone Cypionate in Hawaii

Commercial insurance plans in Hawaii cover testosterone cypionate more readily than Medicaid, though coverage rules vary significantly by carrier and plan tier. The major insurers operating in Hawaii include HMSA (Blue Cross Blue Shield affiliate), Kaiser Permanente Hawaii, UnitedHealthcare, and AlohaCare.

HMSA, the largest insurer in the state covering roughly 50% of Hawaii's insured population, generally covers generic testosterone cypionate with a prior authorization. The typical copay for a preferred generic on an HMSA plan ranges from $10 to $35 per month. Kaiser Permanente Hawaii covers testosterone cypionate within its formulary for members with documented hypogonadism and often fills prescriptions through its own pharmacy network, which simplifies the process 2.

Prior authorization requirements are the norm across all Hawaii commercial plans. Insurers typically require:

• Two fasting morning serum testosterone levels below 300 ng/dL
• Documentation of signs or symptoms (fatigue, decreased libido, reduced muscle mass, depressed mood)
• Exclusion of reversible causes such as opioid use, obesity, or pituitary pathology
• Initial prescriber must be an endocrinologist, urologist, or primary care physician

The T-Trials (Testosterone Trials), a coordinated set of seven placebo-controlled studies involving 790 men aged 65 and older with serum testosterone below 275 ng/dL, demonstrated that one year of testosterone gel treatment improved sexual function, physical activity, and mood compared to placebo 1. Insurers frequently reference these findings when setting coverage criteria.

Telehealth TRT in Hawaii: A Growing Option

Hawaii permits telehealth prescribing of testosterone cypionate by licensed physicians. This is legal. The state adopted permanent telehealth parity legislation that requires insurers to cover telehealth services at the same rate as in-person visits, removing a significant barrier for patients on neighbor islands who may lack local endocrinology or urology specialists.

Telehealth TRT clinics operating in Hawaii typically charge $99 to $199 per month for a subscription that bundles physician consultations, lab monitoring, and sometimes the medication itself. When medication is bundled, the testosterone usually ships from a mainland 503B outsourcing facility directly to the patient's Hawaii address. Patients who prefer to fill at a local pharmacy can obtain a standard prescription from their telehealth provider and pay the retail cash price or use insurance.

The Endocrine Society guideline explicitly recommends monitoring hematocrit, PSA, and liver function at baseline and 3 to 6 months after starting testosterone therapy, then annually thereafter 2. Reputable telehealth clinics incorporate this monitoring into their protocols. A 2020 meta-analysis in the Journal of Clinical Endocrinology & Metabolism examining testosterone therapy safety across 35 randomized trials (N=5,601) found no statistically significant increase in major adverse cardiovascular events with testosterone treatment compared to placebo 5.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, noted in a 2019 review: "The weight of evidence does not support an increased cardiovascular risk with testosterone therapy when administered to appropriately diagnosed hypogonadal men under proper medical supervision" 5. This evidence base supports the safety of telehealth-managed TRT when monitoring protocols are followed.

Finding the Cheapest Testosterone Cypionate in Hawaii

Several strategies can reduce your testosterone cypionate costs below the $60 per month average in Hawaii.

Generic savings cards and manufacturer coupons. Various generic testosterone cypionate manufacturers offer savings cards that reduce the cash price by $15 to $30 per fill at participating pharmacies. These cards work at most chain pharmacies in Hawaii, including CVS (Longs Drugs in Hawaii), Walgreens, Walmart, and Costco. The cards are free, require no insurance, and can be used on each refill. Check the specific manufacturer's website for the most current card terms, as programs change annually.

Pharmacy price shopping. Prices for the same generic testosterone cypionate vial can vary by $20 to $40 between pharmacies on the same island. Costco pharmacies consistently price generics lower than competitors because of their bulk purchasing model, and you do not need a Costco membership to use their pharmacy. The Costco in Iwilei (Honolulu) and Kapolei frequently rank among the lowest-priced pharmacies in the state for injectable testosterone.

90-day fills. If your insurer covers testosterone cypionate, request a 90-day supply. This reduces per-unit cost and eliminates monthly pharmacy trips. For cash-pay patients, a 90-day fill at a single pharmacy often comes with a per-vial discount compared to monthly fills.

GoodRx and similar discount platforms. Free discount aggregators can lower the price to $30 to $45 per month at select Hawaii pharmacies. These platforms negotiate rates with pharmacy benefit managers and pass savings to the consumer. Prices update weekly, so check before each fill 6.

Compounding as a last resort. At $80 per month, compounded testosterone is actually more expensive than generic in Hawaii. Use compounding only when you have a clinical reason, not for cost savings.

Understanding Your Testosterone Cypionate Prescription

Testosterone cypionate is a Schedule III controlled substance under both federal and Hawaii state law. This classification carries specific implications for how prescriptions are written and filled.

Hawaii pharmacies can dispense up to a 90-day supply per fill, and prescriptions may include up to five refills within a six-month period from the date written. After six months, a new prescription is required. Controlled substance prescriptions in Hawaii must be transmitted electronically (EPCS) or on tamper-resistant paper, per Hawaii Administrative Rules Title 16, Chapter 95 4.

The standard testosterone cypionate regimen for hypogonadism is 100 to 200 mg administered by intramuscular injection every one to two weeks, per the FDA-approved labeling for Depo-Testosterone 7. Many clinicians now prefer more frequent lower-dose protocols (50 to 80 mg twice weekly or even every-other-day subcutaneous injections) to reduce peak-to-trough fluctuations in serum testosterone. The Endocrine Society guideline supports dose adjustments to maintain mid-normal range testosterone (400 to 700 ng/dL) at trough 2.

Subcutaneous injection of testosterone cypionate, while technically off-label, has gained substantial clinical acceptance. A 2017 study published in the Journal of Clinical Endocrinology & Metabolism (N=232) demonstrated that subcutaneous testosterone cypionate produced equivalent serum testosterone levels to intramuscular injection with fewer injection-site reactions 8. This route uses a smaller needle (typically 25 to 27 gauge, 5/8 inch), making self-injection more accessible for patients.

Lab Monitoring Costs to Factor In

The price of testosterone cypionate itself represents only part of the total cost of TRT. Lab monitoring adds $200 to $600 annually depending on insurance status and testing frequency.

Baseline labs before starting TRT should include total testosterone (two morning fasting draws), free testosterone, complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panel, PSA (for men over 40), estradiol, and LH/FSH. Follow-up labs at 3 months, 6 months, and annually thereafter typically include total testosterone, CBC with hematocrit, PSA, and a metabolic panel 2.

Hematocrit monitoring is particularly important. The T-Trials reported that testosterone treatment increased hematocrit by an average of 3.2 percentage points compared to placebo, and approximately 3.5% of testosterone-treated men exceeded a hematocrit of 54%, the threshold at which dose reduction or phlebotomy is recommended 1. Hawaii has several direct-to-consumer lab testing options through Quest Diagnostics and LabCorp locations on Oahu, Maui, and the Big Island. A basic TRT monitoring panel through a direct-to-consumer service runs $50 to $100 per draw without insurance.

For insured patients, these labs are typically covered as preventive or diagnostic testing with standard copays. The total annual out-of-pocket for a cash-pay TRT patient in Hawaii, including medication and labs, ranges from $900 to $1,400 depending on pharmacy choice and lab testing frequency.